We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Adaptive Biotechnologies Announces a Collaboration with Sanofi

News   May 30, 2018 | Original story from Adaptive Biotechnologies

 
Adaptive Biotechnologies Announces a Collaboration with Sanofi

Credit: Adaptive Biotechnologies

 
 
 

RELATED ARTICLES

Bacterial ‘Sleeper Cells’ Evade Antibiotics and Weaken Defence Against Infection

News

These bacteria persister cells stop replicating and can remain in this dormant, ‘sleeper-cell’ state for days, weeks or even months. When antibiotic treatment has been stopped, if some of these bacterial cells spring back to life, they can trigger another infection.

READ MORE

Multigene Test Facilitates Targeted Use of Chemotherapy for Breast Cancer

News

New results show that the multigene test used at the university hospital in Munich is indeed helpful in making more targeted use of chemotherapy treatments and thus improves prognosis of breast cancer patients.

READ MORE

Antibiotics Generated from Wasp Venom

News

Altered peptides from a South American wasp’s venom can kill bacteria but are nontoxic to human cells.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE